{"id":19072,"date":"2021-02-26T15:35:57","date_gmt":"2021-02-26T14:35:57","guid":{"rendered":"https:\/\/www.hollandbio.nl\/?p=19072"},"modified":"2021-02-26T15:35:58","modified_gmt":"2021-02-26T14:35:58","slug":"novalgen-enters-strategic-partnership-with-halix-b-v-to-manufacture-clinical-trial-materials","status":"publish","type":"post","link":"https:\/\/www.hollandbio.nl\/en\/nieuws\/novalgen-enters-strategic-partnership-with-halix-b-v-to-manufacture-clinical-trial-materials\/","title":{"rendered":"NovalGen Enters Strategic Partnership with HALIX B.V. to Manufacture Clinical Trial Materials"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">NovalGen Ltd. (\u201cNovalGen\u201d), a biopharmaceutical company developing breakthrough cancer therapies and HALIX B.V. (\u201cHALIX\u201d), a contract development and manufacturing organisation, today announced a strategic partnership. Within the scope of this partnership, HALIX will provide manufacturing of clinical supply of NovalGen\u2019s therapies.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">NovalGen\u2019s innovative platform technology has been successfully deployed at HALIX to manufacture clinical trial material for NovalGen\u2019s first clinical program. The program, NVG-111, is a Receptor Tyrosine Kinase Like Orphan Like Receptor 1 (ROR1) targeting bispecific antibody T cell engager for the treatment of hematologic malignancies and solid tumors, is expected to enter the clinic in the first half of 2021. HALIX has supported NovalGen with the successful completion of GMP manufacture of NVG-111 from drug substance up to drug product and final release. The strategic partnership and collective expertise of both organisations has ensured an efficient technology transfer and further development of the process leading to a successful GMP manufacturing campaign.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u201cThis collaboration with HALIX will ensure high quality, rapid and secure manufacture of clinical supplies for our current and future products. Using cutting-edge manufacturing technologies at our partner\u2019s state-of-the-art cGMP facility, we are progressing to become a clinical stage company,\u201d<strong> said Kieran O<\/strong><strong>\u2019<\/strong><strong>Donovan, SVP Chemistry and Manufacturing Controls at NovalGen<\/strong>. \u201cWe developed a manufacturing process around the use of transient transfection to accelerate timelines and reduce costs, whilst delivering product of the highest quality. In HALIX we found the ideal partner; experience in transient transfection, modern facilities, strong leadership and a laser focus on delivery to bring NVG-111 from contract signature to vials of clinical drug in less than seven months.\u201d<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u201cThe partnership with NovalGen has been a great success,\u201d<strong> said Alex Huybens, Chief Operations Officer at HALIX<\/strong>. \u201cWorking closely together and utilizing the collective bispecific antibody expertise of both teams has enabled us to meet the ambitious timelines and efficiently transfer the process and deliver the product to be ready to enter the clinic. We look forward to a long and productive collaboration with NovalGen.\u201d<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Source: HALIX (<a href=\"https:\/\/www.halix.nl\/2021\/02\/22\/novalgen-enters-strategic-partnership-halix-b-v-manufacture-clinical-trial-materials\/\">Press release<\/a>) <\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>NovalGen Ltd. (\u201cNovalGen\u201d), a biopharmaceutical company developing breakthrough cancer therapies and HALIX B.V. (\u201cHALIX\u201d), a contract development and manufacturing organisation, today announced a strategic partnership. Within the scope of this partnership, HALIX will provide manufacturing of clinical supply of NovalGen\u2019s therapies. NovalGen\u2019s innovative platform technology has been successfully deployed at HALIX to manufacture clinical trial [&hellip;]<\/p>\n","protected":false},"author":16,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[43],"tags":[],"class_list":["post-19072","post","type-post","status-publish","format-standard","hentry","category-innovatieklimaat"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>NovalGen Enters Strategic Partnership with HALIX B.V. to Manufacture Clinical Trial Materials - hollandbio<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.hollandbio.nl\/en\/nieuws\/novalgen-enters-strategic-partnership-with-halix-b-v-to-manufacture-clinical-trial-materials\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NovalGen Enters Strategic Partnership with HALIX B.V. to Manufacture Clinical Trial Materials - hollandbio\" \/>\n<meta property=\"og:description\" content=\"NovalGen Ltd. (\u201cNovalGen\u201d), a biopharmaceutical company developing breakthrough cancer therapies and HALIX B.V. (\u201cHALIX\u201d), a contract development and manufacturing organisation, today announced a strategic partnership. Within the scope of this partnership, HALIX will provide manufacturing of clinical supply of NovalGen\u2019s therapies. NovalGen\u2019s innovative platform technology has been successfully deployed at HALIX to manufacture clinical trial [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.hollandbio.nl\/en\/nieuws\/novalgen-enters-strategic-partnership-with-halix-b-v-to-manufacture-clinical-trial-materials\/\" \/>\n<meta property=\"og:site_name\" content=\"hollandbio\" \/>\n<meta property=\"article:published_time\" content=\"2021-02-26T14:35:57+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-02-26T14:35:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2025\/01\/hb-opengraph_illu.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"HollandBIO\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@hollandbio\" \/>\n<meta name=\"twitter:site\" content=\"@hollandbio\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"HollandBIO\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/novalgen-enters-strategic-partnership-with-halix-b-v-to-manufacture-clinical-trial-materials\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/novalgen-enters-strategic-partnership-with-halix-b-v-to-manufacture-clinical-trial-materials\\\/\"},\"author\":{\"name\":\"HollandBIO\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#\\\/schema\\\/person\\\/48824449f08e494bb7ea02e1ff5dd6ea\"},\"headline\":\"NovalGen Enters Strategic Partnership with HALIX B.V. to Manufacture Clinical Trial Materials\",\"datePublished\":\"2021-02-26T14:35:57+00:00\",\"dateModified\":\"2021-02-26T14:35:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/novalgen-enters-strategic-partnership-with-halix-b-v-to-manufacture-clinical-trial-materials\\\/\"},\"wordCount\":350,\"publisher\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#organization\"},\"articleSection\":[\"Innovatieklimaat\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/novalgen-enters-strategic-partnership-with-halix-b-v-to-manufacture-clinical-trial-materials\\\/\",\"url\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/novalgen-enters-strategic-partnership-with-halix-b-v-to-manufacture-clinical-trial-materials\\\/\",\"name\":\"NovalGen Enters Strategic Partnership with HALIX B.V. to Manufacture Clinical Trial Materials - hollandbio\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#website\"},\"datePublished\":\"2021-02-26T14:35:57+00:00\",\"dateModified\":\"2021-02-26T14:35:58+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/novalgen-enters-strategic-partnership-with-halix-b-v-to-manufacture-clinical-trial-materials\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/novalgen-enters-strategic-partnership-with-halix-b-v-to-manufacture-clinical-trial-materials\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/novalgen-enters-strategic-partnership-with-halix-b-v-to-manufacture-clinical-trial-materials\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NovalGen Enters Strategic Partnership with HALIX B.V. to Manufacture Clinical Trial Materials\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/\",\"name\":\"hollandbio\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#organization\",\"name\":\"hollandbio\",\"url\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.hollandbio.nl\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/HollandBIO_logo.svg\",\"contentUrl\":\"https:\\\/\\\/www.hollandbio.nl\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/HollandBIO_logo.svg\",\"width\":218.664,\"height\":29.659,\"caption\":\"hollandbio\"},\"image\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/hollandbio\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/hollandbio\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#\\\/schema\\\/person\\\/48824449f08e494bb7ea02e1ff5dd6ea\",\"name\":\"HollandBIO\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"NovalGen Enters Strategic Partnership with HALIX B.V. to Manufacture Clinical Trial Materials - hollandbio","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.hollandbio.nl\/en\/nieuws\/novalgen-enters-strategic-partnership-with-halix-b-v-to-manufacture-clinical-trial-materials\/","og_locale":"en_US","og_type":"article","og_title":"NovalGen Enters Strategic Partnership with HALIX B.V. to Manufacture Clinical Trial Materials - hollandbio","og_description":"NovalGen Ltd. (\u201cNovalGen\u201d), a biopharmaceutical company developing breakthrough cancer therapies and HALIX B.V. (\u201cHALIX\u201d), a contract development and manufacturing organisation, today announced a strategic partnership. Within the scope of this partnership, HALIX will provide manufacturing of clinical supply of NovalGen\u2019s therapies. NovalGen\u2019s innovative platform technology has been successfully deployed at HALIX to manufacture clinical trial [&hellip;]","og_url":"https:\/\/www.hollandbio.nl\/en\/nieuws\/novalgen-enters-strategic-partnership-with-halix-b-v-to-manufacture-clinical-trial-materials\/","og_site_name":"hollandbio","article_published_time":"2021-02-26T14:35:57+00:00","article_modified_time":"2021-02-26T14:35:58+00:00","og_image":[{"width":1200,"height":675,"url":"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2025\/01\/hb-opengraph_illu.png","type":"image\/png"}],"author":"HollandBIO","twitter_card":"summary_large_image","twitter_creator":"@hollandbio","twitter_site":"@hollandbio","twitter_misc":{"Written by":"HollandBIO","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/novalgen-enters-strategic-partnership-with-halix-b-v-to-manufacture-clinical-trial-materials\/#article","isPartOf":{"@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/novalgen-enters-strategic-partnership-with-halix-b-v-to-manufacture-clinical-trial-materials\/"},"author":{"name":"HollandBIO","@id":"https:\/\/www.hollandbio.nl\/en\/#\/schema\/person\/48824449f08e494bb7ea02e1ff5dd6ea"},"headline":"NovalGen Enters Strategic Partnership with HALIX B.V. to Manufacture Clinical Trial Materials","datePublished":"2021-02-26T14:35:57+00:00","dateModified":"2021-02-26T14:35:58+00:00","mainEntityOfPage":{"@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/novalgen-enters-strategic-partnership-with-halix-b-v-to-manufacture-clinical-trial-materials\/"},"wordCount":350,"publisher":{"@id":"https:\/\/www.hollandbio.nl\/en\/#organization"},"articleSection":["Innovatieklimaat"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/novalgen-enters-strategic-partnership-with-halix-b-v-to-manufacture-clinical-trial-materials\/","url":"https:\/\/www.hollandbio.nl\/en\/nieuws\/novalgen-enters-strategic-partnership-with-halix-b-v-to-manufacture-clinical-trial-materials\/","name":"NovalGen Enters Strategic Partnership with HALIX B.V. to Manufacture Clinical Trial Materials - hollandbio","isPartOf":{"@id":"https:\/\/www.hollandbio.nl\/en\/#website"},"datePublished":"2021-02-26T14:35:57+00:00","dateModified":"2021-02-26T14:35:58+00:00","breadcrumb":{"@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/novalgen-enters-strategic-partnership-with-halix-b-v-to-manufacture-clinical-trial-materials\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.hollandbio.nl\/en\/nieuws\/novalgen-enters-strategic-partnership-with-halix-b-v-to-manufacture-clinical-trial-materials\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/novalgen-enters-strategic-partnership-with-halix-b-v-to-manufacture-clinical-trial-materials\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.hollandbio.nl\/en\/"},{"@type":"ListItem","position":2,"name":"NovalGen Enters Strategic Partnership with HALIX B.V. to Manufacture Clinical Trial Materials"}]},{"@type":"WebSite","@id":"https:\/\/www.hollandbio.nl\/en\/#website","url":"https:\/\/www.hollandbio.nl\/en\/","name":"hollandbio","description":"","publisher":{"@id":"https:\/\/www.hollandbio.nl\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.hollandbio.nl\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.hollandbio.nl\/en\/#organization","name":"hollandbio","url":"https:\/\/www.hollandbio.nl\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.hollandbio.nl\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2023\/08\/HollandBIO_logo.svg","contentUrl":"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2023\/08\/HollandBIO_logo.svg","width":218.664,"height":29.659,"caption":"hollandbio"},"image":{"@id":"https:\/\/www.hollandbio.nl\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/hollandbio","https:\/\/www.linkedin.com\/company\/hollandbio\/"]},{"@type":"Person","@id":"https:\/\/www.hollandbio.nl\/en\/#\/schema\/person\/48824449f08e494bb7ea02e1ff5dd6ea","name":"HollandBIO"}]}},"_links":{"self":[{"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/posts\/19072","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/comments?post=19072"}],"version-history":[{"count":0,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/posts\/19072\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/media?parent=19072"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/categories?post=19072"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/tags?post=19072"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}